Janux Therapeutics, Inc. (JANX) vs Kura Oncology, Inc. (KURA)
Janux Therapeutics, Inc. and Kura Oncology, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and Kura Oncology, Inc. are of similar size ($1.0B and $977.7M). Kura Oncology, Inc. has the higher net margin (−384.3% vs −427.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Janux Therapeutics, Inc. leads on 10 and Kura Oncology, Inc. on 5.
Valuation
Profitability
| Metric | JANX | KURA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.35% | 65.16% |
| Operating margin | (598.15%) | (411.90%) | 0.00% |
| Net margin | (427.47%) | (384.30%) | 0.00% |
| Free cash flow margin | (174.69%) | (152.06%) | 0.00% |
| Return on equity | (10.70%) | (167.71%) | (57.72%) |
| Return on assets | (10.06%) | (46.73%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack